Navigation Links
NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus
Date:4/20/2009

NCCN has added everolimus (Afinitor(R), Novartis) to the NCCN Guidelines for Kidney Cancer as a recommended treatment for patients with renal cell carcinoma whose disease has progressed after treatment with kinase inhibitors. This recommendation comes on the heels of the March 30, 2009 FDA approval of everolimus based upon results of a clinical trial which showed that the therapy significantly extended progression-free survival in a specific group of patients.

FORT WASHINGTON, Pa., April 20 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) has updated the NCCN Clinical Practice Guidelines in Oncology(TM) for Kidney Cancer to reflect the recent FDA approval of everolimus (Afinitor(R), Novartis) for advanced renal cell carcinoma in patients whose disease has progressed after treatment with kinase inhibitors such as sunitinib (Sutent(R), Pfizer Inc.) and sorafenib (Nexavar(R), Bayer HealthCare).

The FDA approval is based on recent results of a clinical trial which showed that the growth or spread of tumors was delayed in patients who were being treated with everolimus and that the treatment improved median progression-free survival to 4.9 months compared to 1.9 months in patients who did not receive the treatment.

Based on this trial data, the NCCN Guidelines Panel for Kidney Cancer has added everolimus as a category 1 option for patients with metastatic renal cell carcinoma following failure of tyrosine kinase therapy.

Everolimus targets a protein known as mTOR, which affects tumor cell division, angiogenesis, and cell metabolism. The mTOR pathway integrates signals from nutrients and growth factors and is considered to be a major regulator of cell growth and angiogenes
'/>"/>

SOURCE National Comprehensive Cancer Network
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Carriage Services Updates Company & Investment Profile
2. China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
3. NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma
4. New NCCN Guidelines for Primary Cutaneous B-Cell Lymphoma and Updates to NCCN Guidelines for Non-Hodgkins Lymphomas
5. NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines
6. BullMarket.com Updates Outlook on Biotech Stocks
7. Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
8. Cell Therapeutics Updates Shareholders on Trading
9. Service Corporation International Updates Fourth Quarter 2008 Guidance
10. NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines
11. LegalView Updates Avandia Information Portal With New Articles Detailing Potentially Dangerous Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... New Orleans, LA The National Science Foundation ... a Research Experiences for Undergraduates (REU) Site grant ... support the training of undergraduates from diverse social ... from the New Orleans area. The project ... during the summers of 2014-16. It will ...
(Date:4/24/2014)... University of York reveals that a process that forms ... system may also play a pivotal role in the ... by Dr Will Brackenbury, a Medical Research Council Fellow ... how voltage-gated sodium channels assist in the metastasis of ... of excitable cells, such as neurons, where they are ...
(Date:4/23/2014)... frozen stool from healthy, unrelated donors was safe ... diarrhea caused by Clostridium difficile , according ... Clinical Infectious Diseases and available online. Known ... effective whether given via a colonoscope or a ... make this promising treatment more readily available to ...
(Date:4/23/2014)... for a new experimental drug to treat acute ... with CPX-351, a combination of the chemotherapeutic drugs ... patients treated with the standard drug formulation. ... aggressive blood cancer with very low rates of ... Lancet, M.D., senior member of the Department of ...
(Date:4/23/2014)... National Institute of Arthritis and Musculoskeletal and Skin Diseases ... Ross Prize in Molecular Medicine, conferred by the Feinstein ... award will be given on June 9 at the ... scientific presentations by Dr. O,Shea and other prominent researchers. ... , The award, which includes a $50,000 prize from ...
Breaking Medicine News(10 mins):Health News:Breast cancer replicates brain development process 2Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2
... care to dialysis patients ... ... of kidney care services, announced today that its specialty renal,pharmacy, DaVita ... today during a special celebration at DaVita Rx,headquarters in Dallas. DaVita(R) ...
... Mutual Insurance Company,(TMIC) said it would appeal to the ... Court of Appeals., The 14th Court rejected Texas ... in Harris County found TMIC acted in bad faith ... The jury also had found,that plaintiff P. Lance Morris ...
... of Charity Health System Continues to Jeopardize Patient ... Thousands of,healthcare workers will hold a one-day strike ... the Daughters of Charity Health System.,Caregivers were forced ... fairly over proposals aimed to help ensure quality ...
... University,s Slone Epidemiology Center have found that in a given ... than 4 million are taking them regularly (at least five ... findings appear in the August 31 issue of the journal ... the treatment of moderate to severe pain and are among ...
... college students understand how they can prevent the transmission of ... a new University of Georgia study. , Su-I Hou, associate ... than 500 students and found that they scored higher on ... than items specifically related to HIV testing (72 percent correct). ...
... Pa., Aug. 26 Philadelphia,Insurance Companies (Nasdaq: ... through its partnership with Life Insurance Company of ... a variety of niches,including non-profits, social service and ... abuse rehabilitation facilities.,The plan provides up to $100,000 ...
Cached Medicine News:Health News:Specialty Renal Pharmacy Delivers One Millionth Prescription 2Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 2Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 3Health News:Texas Mutual Insurance to Appeal 14th Court's Decision to Texas Supreme Court 4Health News:Thousands of California Healthcare Workers Strike to Protect Their Patients 2Health News:Study examines use of opioids 2Health News:Study reveals gap in HIV testing knowledge among college students 2
(Date:1/15/2014)... 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... patent application concerning composition of matter, biological targets, mechanism ... cell death.  This patent application describes ... RNA molecules (VSRNAs) which interfere with the basic homeostatic ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... joins teleconference to release report with ITPC. Kim says,foundations ... ever had to,build comprehensive health systems in the poorest ... Nov.27 ,The International Treatment Preparedness Coalition (ITPC), a group ... issued its fifth,report on scale up of AIDS services: ...
... Nov. 27 ,Computer Sciences Corporation (NYSE: CSC ... a CSC company, in conjunction with Baxter,International Inc. ... million contract,modification from the U.S. Department of Health ... cell-cultured seasonal and pandemic,influenza candidate vaccines. CSC reported ...
Cached Medicine Technology:New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target 2New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target 3New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target 4U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter 2U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter 3
Each slide contains an A.F.B. positive staining control of Mycobacterium scrofulaceum ATCC ® 19981 in simulated sputum and an A.F.B. negative staining control of Escherichia coli ATCC ® 25922...
... Equalizer With 384 Well Plate Capability ... of the original Equalizerexpandable and equal tip spacing, ... in-lab calibration capabilities. In addition, this model allows ... 4.5mm for loading and accessing many gels and ...
... Exp Expandable Tip System A ... System allows you to perform multi-sample transfers between ... pull of a knob, tip spacing can be ... microcentrifuge tubes) or 96 well plates. Ergonomic ...
... Exp Expandable Tip System A lower ... allows you to perform multi-sample transfers between two ... of a knob, tip spacing can be quickly ... tubes) or 96 well plates. Ergonomic Design ...
Medicine Products: